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Abstract
Infection by Chromobacterium violaceum, known as chromobacte-
riosis, is a rare cause of severe sepsis with rapid spread and high 
mortality. In February 2009, a 14-year-old male patient was admitted 
to Santa Casa of Misericórdia of Juiz de Fora Hospital, and he dete-
riorated rapidly with severe sepsis and death by chromobacteriosis. In 
this article we discuss the main clinical findings, sensitivity profile, and 
antimicrobial therapy of this case.
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Introduction
The Chromobacterium violaceum is a bacillus or coco-bacillus-shaped 
bacterium which is Gram-negative, facultative anaerobic, and usually 
lives in water or soil in tropical and subtropical regions [1-5] The most 
striking feature of this type of bacteria is the production of a pigment 
called violacein, colouring the colonies violet. However, 9% of the 
isolated strains do not have pigments [1].
The first description of Chromobacterium violaceum occurred in the 
Philippines in 1905 [3, 6-8], and the first report of human infection 
occurred in 1927 in Malaysia [1, 3, 7] and the Southeast Asian region 
has the highest number of cases reported [2, 3]. In Brazil the first 
case was reported in 1984 and occurred in the Rio Negro region, in 
the Amazon [3]. There have been an estimated 150 cases worldwide 
and 19 cases in Brazil [1] in total. The infection caused by this agent 
rarely affects humans, can occur in healthy or immunocompromised 
individuals [1, 4, 5], and is known as chromobacteriosis. It is charac-
terized by rapid spread, with severe sepsis and high mortality [2, 3, 
9]. Transmission usually occurs through contact of open wounds with 
contaminated water [1, 3, 8].
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This article describes the occurrence of chromo-
bacteriosis in a 14-year-old male patient, from the 
municipality of Simão Pereira, state of Minas Gerais, 
Brazil. The patient was transferred in to Santa Casa 
of Misericórdia of Juiz de Fora Hospital, a regio-
nal reference hospital, where he was seen by the 
Infectious Diseases service. The clinical course and 
identification of the infectious agent also took place 
at this hospital. 
Clinical Case
Male patient, 14 years old, mixed race, student, 
born in the city of Juiz de Fora and resident of Simão 
Pereira, Minas Gerais, was referred to Santa Casa 
of Misericórdia of Juiz de Fora Hospital. He was ad-
mitted in February 2009, 1:00 am, with reports of 
having suffered blunt trauma injury in the anterior 
region of the right leg two weeks before. The lesion 
developed signs of inflammation associated with a 
fever of 39°C and the appearance of large-volume 
tumor on the right inguinal region, without hype-
remia, increased temperature, or local pain. With 
this condition he was hospitalized in his hometown 
and received intravenous antibiotic treatment with 
ceftriaxone. Still unresolved a few days later, he 
was admitted by our service. He denied previous 
diseases or allergies. He reported exposure to flood 
waters, during which the said injury occurred on his 
right leg.
The referral documents included only a comple-
te blood count with leukocytosis (predominance of 
neutrophils without deviation for juvenile forms) 
and urinalysis with pyuria of 10 pus cells per field, 
without other changes. No other report or testing 
was included.
During the physical examination on admission, 
the patient had a Glasgow score of 15, feverish with 
axillary temperature of 38.5°C. Cardiovascular sys-
tem with regular heart rhythm without murmurs 
on auscultation, blood pressure of 110 x 60 mmHg, 
heart rate of 96 beats per minute and no patho-
logical jugular venous distension. Auscultation re-
vealed no adventitious sounds, breath sounds were 
globally distributed, respiratory rate of 20 breaths 
per minute and absence of respiratory effort. The 
abdomen was normal to inspection and palpation, 
without visceral enlargement and with physiological 
bowel sounds. Neurological examination without 
abnormalities in consciousness level, balance, stren-
gth and muscle tone, sensitivity or motor function, 
with no signs of meningeal irritation. There was 
presence of inguinal lymphadenopathy without 
signs of inflammation. On the lower right leg there 
was a blunt injury on the anterior region with flus-
hing, increased temperature and secretion of small 
amounts of pus.
At 6:00 am, the patient developed chest pain 
in precordium, beginning 20 minutes before, with 
an oppressive and ventilator-dependent aspect re-
sistant to conventional analgesia. On this occasion 
he presented tachycardia with a heart rate of 120 
beats per minute, slightly hypotensive with a blood 
pressure of 85 x 60 mmHg. Resting electrocardio-
gram was performed, without changes in addition 
to sinus tachycardia; respiratory rate of 20 breaths 
per minute. Volume expansion was started, with 
crystalloid, intravenous antibiotic therapy was pres-
cribed (oxacillin and ceftriaxone), and further testing 
was requested.
Hours later, at 8:00 am, the patient developed 
dyspnea and cyanosis, with persisting hypotension 
(80 x 40 mmHg), tachycardia, and now with tachyp-
nea (respiratory rate of 32 breaths per minute). He 
was then transferred to intensive care.
Initial testing showed pancytopenia with: he-
moglobin 10.6 mg/dl, leukopenia 300 cells/mm3 
and platelets of 80,000/mm3. Ureia, serum creati-
nine, sodium, and potassium were normal, d-dimer 
was high, and serum lactate was also very high at 
15,9 mg/dl. Testing revealed metabolic acidosis and 
hypoxemia. Chest x-ray (Figure 1) with small scatte-
red nodules in both pleuropulmonary fields without 
pleural effusion and with preserved cardiac area. 
Echocardiography without valvular or flow altera-
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tions on Doppler, normal pericardium, left ventri-
cular volumes within normal limits, and a reduced 
ejection fraction of 46.77%. Inguinal ultrasound 
showed the presence of enlarged lymph nodes (4 x 
2 cm), with areas of liquefaction. Blood for culture 
was also collected.
The patient was submitted to tracheal intubation 
and mechanical ventilation, vasoactive drugs were 
started, maintaining the strong volume expansion 
with crystalloids; intravenous corticosteroids were 
started and antimicrobial treatment was altered, 
with cefepime added to oxacillin. He remained 
hypotensive, tachycardic and hypoxic despite the 
initial measures. He had a white blood cell count of 
900 cells/mm3 even after administration of neutro-
phil colonies stimulator. A biopsy of inguinal lymph 
nodes was performed. 
At 5:00 pm he suffered his first cardiac arrest, 
with successful resuscitation, and at 7:00 pm the 
patient died.
A few days later the results of the lymph node 
biopsy and blood culture were made available. The 
biopsy showed no microscopic abnormalities and 
lymph node culture was negative. Blood culture 
grew Chromobacterium violaceum. The bacteria 
was sensitive to ciprofloxacin, levofloxacin and sul-
famethoxazole-trimethoprim, had intermediate re-
sistance to amikacin, gentamicin, tobramycin, and 
resistance to aztreonam, imipenem, ceftazidime, 
cefepime, ceftriaxone and piperacillin-tazobactam.
Discussion
The clinical condition presented by this patient was 
characterized by the quick evolution of a febrile 
syndrome into severe sepsis and death. Upon ad-
mission at Santa Casa of Misericórdia of Juiz de 
Fora Hospital, the patient was initially suspected 
of having leptospirosis due to exposure to flood 
waters, which is also the vehicle of infection for 
chromobacteriosis [1, 3]. After initial laboratory 
testing, additional diagnostic hypotheses were 
staphylococcal sepsis evolving with severe neutro-
penia and lymphoproliferative syndrome with the 
presence of lymph node enlargement, presenting 
with leukopenia, which would be a characteris-
tic of a serious and sudden sepsis in the context 
of neutropenia. These diagnoses were assessed 
through Doppler echocardiography, blood culture 
and biopsy of inguinal lymph nodes, and general 
laboratory testing and chest X-ray. The etiologic 
diagnosis was established only after the isolation 
of Chromobacterium violaceum in blood culture 
days after the patient's death. 
Chromobacterium violaceum is not a demanding 
bacteria type, easily growing in standard culture 
media (1:10). Its violet coloration is due to the pre-
sence of the violacein pigment [1, 3, 7] which has 
commercial and industrial importance due to its an-
Figure 1:  Chest X-ray with scattered small no-
dules in both pleuropulmonary fields 
without pleural effusion and with pre-
served cardiac area.
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tibacterial, anti-parasitic, and anti-tumor properties, 
and its use in the manufacture of biosurfactants [1, 
11]. 
The clinical manifestations of chromobacteriosis 
begin after the incubation period ranging from 3 
to 14 days, according to the form of exposure to 
the agent [1, 8]. It includes inflammatory signs at 
the entry site, associated with fever, nausea, vomi-
ting, abdominal pain [1, 3, 4] with rapid evolution 
to sepsis, rapid spread and high mortality [2, 3, 12, 
13]. There is formation of multiple abscesses in the 
lung, liver, spleen, brain (more rarely), as well as 
cellulite, lymphadenitis and osteomyelitis [1-3, 6, 7, 
12, 14]. Other symptoms include conjunctivitis, dia-
rrhea, urinary tract infections, sinusitis and menin-
gitis [5, 8, 10].
Some patients may have persistent micro absces-
ses and septic foci after treatment, specially those 
who did not follow adequate treatment [4].
Laboratory findings are nonspecific, and there are 
changes in the blood count, such as leukocytosis, 
leukopenia and left shift. Definitive diagnosis of in-
fection is done by culture and subsequent bioche-
mical testing [4, 10]. There are no serological tests 
for this indication [4].
Antimicrobial therapy against chromobacteriosis 
may be difficult to select, since Chromobacterium 
violaceum is resistant to most agents used in the 
medical practice, such as penicillins and cephalos-
porins [1].
The mechanisms involved in bacterial resistance 
to beta-lactam agents are: presence of beta-lacta-
mases and absence of penicillins receptors [12]. The 
presence of efflux pumps is a mechanism present in 
multidrug-resistant strains of bacteria, and are likely 
responsible for resistance to tetracycline, erythromy-
cin and sulfadiazine [12].
Chromobacterium violaceum is usually sensitive in 
vitro to fluoroquinolones, specifically to ciprofloxa-
cin, carbapenems, aminoglycosides, piperacillin, 
trimethoprim-sulfamethoxazole, ceftazidime and 
cefepime [1, 9, 10, 12, 15-17]. Resistance to cepha-
losporins is variable, and it is common to identify 
strains resistant to ceftazidime and cefepime [1, 15, 
17], such as the one isolated in our case report. 
Also as a general rule, the microorganism is resistant 
to ampicillin, amoxicillin, ceftriaxone, cephalexin, ri-
fampin, tetracycline, azithromycin and erythromycin 
[1, 7, 12, 15-18], and may have intermediate resis-
tance to norfloxacin, polymyxin B and cefoxitin [15]. 
The strain isolated in our case was resistant or in-
termediately resistant to antibiotics that are usually 
effective against Chromobacterium violaceum, such 
as imipenem, piperacillin, aminoglycosides, ceftazi-
dime and cefepim, as seen in other reports [18].
The use of ciprofloxacin, a fluoroquinolone against 
which no resistance has been observed, seems to 
be a good therapeutic option, and it is also an an-
tibiotic of widespread use and accepteable cost. [4, 
5, 10].
Conclusion
Chromobacteriosis is an unusual disease in which 
infection occurs through contact of an open wound 
with contaminated water. It has high mortality and 
rapid spread, and an evolution of severe sepsis. The-
re is presence of multiple abscesses in various sites 
such as the lung and liver, and lymphatic dissemina-
tion and phlogosis at the inoculation site.
Evaluating the antimicrobial susceptibility profile 
of Chromobacterium violaceum in several case re-
ports, the authors observed that there is a need to 
better define the most appropriate treatment, since 
the different isolated strains show different profiles, 
however, as a general rule, ciprofloxacin seems to 
be an efficacious choice.
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